Gómez-Moreno G, Guardia J, Aguilar-Salvatierra A, Cabrera-Ayala M, Maté-Sánchez de-Val JE, Calvo-Guirado JL. Effectiveness of malic acid 1% in patients with xerostomia induced by antihypertensive drugs. Med Oral Patol Oral Cir Bucal. 2013 Jan 1;18 (1):e49-55.  

 

 

doi:10.4317/medoral.18206

http://dx.doi.org/doi:10.4317/medoral.18206

 

 

 

1. Cassolato SF, Turnbull RS. Xerostomia: clinical aspects and treatment. Gerodontology. 2003;20:64-77.
http://dx.doi.org/10.1111/j.1741-2358.2003.00064.x

 

2. Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivaly gland hypofunction. J Dent Res. 1992;71:1363-9.
http://dx.doi.org/10.1177/00220345920710070301
PMid:1629451

 

3. Mittal S, Bansal V, Garg S, Atreja G, Bansal S. The diagnostic role of Saliva -A Review. J Clin Exp Dent. 2011;3:e314-20.
http://dx.doi.org/10.4317/jced.3.e314

 

4. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res. 1987;66:648-53.
PMid:3476629

 

5. Wolff MS, Kleinberg I. The effect of ammonium glycopyrrolate (Robinul)-induced xerostomia on oral mucosal wetness and flow of gingival crevicular fluid in humans. Arch Oral Biol. 1999;44:97-102.
http://dx.doi.org/10.1016/S0003-9969(98)00113-7

 

6. Gupta A, Epstein JB, Sroussi H. Hyposalivation in elderly patients. J Can Dent Assoc. 2006;72:841-6.
PMid:17109806

 

7. Silvestre-Donat FJ, Miralles-Jorda L, Martinez-Mihi V. Protocol for the clinical management of dry mouth. Med Oral. 2004;9:273-9.
PMid:15292864

 

8. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med. 2004;15:221-39.
http://dx.doi.org/10.1177/154411130401500405

 

9. Martín-Piedra MA, Gómez-Moreno G, Herrera D, Aguilar-Salvatierra A. Effectiveness of a recent topical sialogogue in the management of drug-induced xerostomia. J Clin Exp Dent. 2011;3:e268-73.
http://dx.doi.org/10.4317/jced.3.e268

 

10. Bergdahl M, Bergdahl J. Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res. 2000;79:1652-8.
http://dx.doi.org/10.1177/00220345000790090301

 

11. Murray Thomson W, Chalmers JM, John Spencer A, Slade GD, Carter KD. A longitudinal study of medication exposure and xerostomia among older people. Gerodontology. 2006;23:205-13.
http://dx.doi.org/10.1111/j.1741-2358.2006.00135.x
PMid:17105501

 

12. de Almeida Pdel V, Grégio AM, Brancher JA, Ignácio SA, Machado MA, de Lima AA, et al. Effects of antidepressants and benzodiazepines on stimulated salivary flow rate and biochemistry composition of the saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:58-65.
http://dx.doi.org/10.1016/j.tripleo.2007.11.008
PMid:18329910

 

13. Thomson WM, Chalmers JM, Spencer AJ, Williams SM. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 1999;16:12-7.
PMid:10697349

 

14. Locker D. Subjective reports of oral dryness in an older adult population. Community Dent Oral Epidemiol. 1993;21:165-8.
http://dx.doi.org/10.1111/j.1600-0528.1993.tb00744.x
PMid:8348792

 

15. Narhi TO. Prevalence of subjective feelings of dry mouth in the elderly. J Dent Res. 1994;73:20-5.
http://dx.doi.org/10.1177/00220345940730010301
PMid:8294614

 

16. Anneroth G, Nordenram G, Bengtsson S. Effect of saliva stimulants (Hybrin and malic acid) on cervical root surfaces in vitro. Scand J Dent Res. 1980;88:214-8.
PMid:6932087

 

17. Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med. 2000;14:197-203.
http://dx.doi.org/10.1191/026921600672294077
PMid:10858827

 

18. da Mata AD, da Silva Marques DN, Silveira JM, Marques JR, de Melo Campos Felino ET, Guilherme NF. Effects of gustatory stimulants of salivary secretion on salivary pH and flow: a randomized controlled trial. Oral Dis. 2009;15:220-8.
http://dx.doi.org/10.1111/j.1601-0825.2009.01513.x
PMid:19220764

 

19. Vissink A, Schaub RM, van Rijn LJ, Gravenmade EJ, Panders AK, Vermey A. The efficacy of mucin-containing artificial saliva in alleviating symptoms of xerostomia. Gerodontology. 1987;6:95-101.
http://dx.doi.org/10.1111/j.1741-2358.1987.tb00283.x
PMid:3505496

 

20. Gravenmade EJ, Vissink A. Mucin-containing lozenges in the treatment of intraoral problems associated with Sjögren's syndrome. A double-blind crossover study in 42 patients. Oral Surg Oral Med Oral Pathol. 1993;75:466-71.
http://dx.doi.org/10.1016/0030-4220(93)90172-Z

 

21. van der Reijden WA, van der Kwaak H, Vissink A, Veerman EC, Amerongen AV. Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome. Arthritis Rheum. 1996;39:57-63.
http://dx.doi.org/10.1002/art.1780390108
PMid:8546739

 

22. Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int. 1998;29:383-8.
PMid:9728149

 

23. Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res. 1982;61:1158-62.
http://dx.doi.org/10.1177/00220345820610100901

 

24. Gambon DL, Brand HS, Nieuw Amerongen AV. The erosive potential of candy sprays. Br Dent J. 2009;206:530-1.
http://dx.doi.org/10.1038/sj.bdj.2009.378
PMid:19404272

 

25. Chunmuang S, Jitpukdeebodintra S, Chuenarrom C, Benjakul P. Effect of xylitol and fluoride on enamel erosion in vitro. J Oral Sci. 2007;49:293-7.
http://dx.doi.org/10.2334/josnusd.49.293
PMid:18195513

 

26. Hove LH, Holme B, Young A, Tveit AB. The protective effect of TiF4, SnF2 and NaF against erosion-like lesions in situ. Caries Res. 2008;42:68-72.
http://dx.doi.org/10.1159/000112816
PMid:18160812